- Price
- $308.78
- Day
- -0.20%
- Mkt Cap
- $60.08B
- 52W Range
- $244.82 – $377.54
- Volume
- 3.28M
- Beta
- 0.57
Find a company by name or ticker and open its page
Breaking news, press releases, and analyst updates.
Most recent articles and analysis covering this company.
Cencora NYSE: COR executives highlighted the company's specialty pharmaceutical positioning, medical specialty organization strategy and capital-allocation priorities during an investor conference discussion, while reaffirming the durability of its relationship with Walgreens.
Read full article
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Read full article
Corient Private Wealth LP lifted its holdings in Cencora, Inc. (NYSE: COR) by 102.9% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 37,601 shares of the company's stock after buying an additional 19,068 shares during the period. Corient Private Wealth LP's
Read full article
Cencora, Inc. (COR) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript
Read full article
Cencora, Inc. (COR) Presents at 2026 Global Healthcare Conference Transcript
Read full article
Bank of America Corp DE purchased a new position in shares of Cencora, Inc. (NYSE: COR) during the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund purchased 3,733,921 shares of the company's stock, valued at approximately $1,056,625,000. Bank of
Read full article
AbbVie is profitable, growing, and paying a rising dividend. CRISPR is burning cash in pursuit of a gene-editing breakthrough that could reshape medicine.
Read full article
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Read full article
Cencora, Inc. (COR) Presents at Wells Fargo 21st Annual Healthcare Conference Transcript
Read full article
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Read full article
COR launches CGT Enablement to help health systems build and scale cell and gene therapy programs with financial, operational and access support.
Read full article
Cencora (COR) reported earnings 30 days ago. What's next for the stock?
Read full article